I hope that is not necessary. Surely they prove safety and efficacy with this trial, although I guess the ultimate goal would be to present data to US FDA, especially after phase 2. Maybe a second phase 2 would be required to get all required data formatted for that? I guess even if that is worst case at least we can go forward now knowing it is safe and effective, just a case of formatting data for more major milestones
- Forums
- ASX - By Stock
- RCE
- Ann: Positive Safety Data from Phase 1 Clinical Trial
Ann: Positive Safety Data from Phase 1 Clinical Trial, page-107
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RCE (ASX) to my watchlist
|
|||||
Last
48.5¢ |
Change
-0.015(3.00%) |
Mkt cap ! $112.3M |
Open | High | Low | Value | Volume |
49.5¢ | 51.5¢ | 48.5¢ | $10.74K | 21.80K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 15892 | 48.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
50.5¢ | 230 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 15892 | 0.485 |
1 | 25000 | 0.480 |
3 | 249999 | 0.475 |
3 | 10641 | 0.470 |
1 | 12500 | 0.465 |
Price($) | Vol. | No. |
---|---|---|
0.505 | 230 | 1 |
0.510 | 9980 | 2 |
0.515 | 1734 | 2 |
0.530 | 11111 | 1 |
0.550 | 29407 | 2 |
Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |